文献速递神经肿瘤

国际鞍结节脑膜瘤研究:预测结局的术前分级量表及内镜下与经颅入路的倾向匹配结局

International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach.
PubMed 文献 · Neurosurgery · 2023-07-07

这项40中心回顾性研究纳入947例鞍结节脑膜瘤患者,验证Magill-McDermott(M-M)分级量表可预测视觉恶化(OR/分:1.22)和全切除(OR/分:0.71),但不预测复发;倾向匹配后经颅入路全切除更可能(OR:1.49),而内镜下入路术前有视觉缺损者视觉改善更可能(72.9% vs 58.4%)。

要点

  • M-M量表可术前预测视觉恶化(OR/分:1.22)和全切除(OR/分:0.71),但不预测复发(P=.4695)。
  • 倾向匹配后经颅入路全切除更可能(OR:1.49,95%CI:1.02-2.18,P=.0409)。
  • 术前有视觉缺损者内镜下入路视觉改善更可能(72.9% vs 58.4%,P=.0010),视觉恶化无差异。

核心结论

  • 简化M-M量表可术前预测视觉恶化和切除程度。
  • 术前有视觉缺损者内镜下入路视觉改善更可能,但选择入路时需考虑个体肿瘤特征。

研究设计与样本

  • 40中心回顾性研究,纳入947例接受鞍结节脑膜瘤切除术的患者,采用标准统计方法和倾向匹配。

主要发现

  • M-M量表预测视觉恶化(OR/分:1.22,95%CI:1.02-1.46,P=.0271)和全切除(OR/分:0.71,95%CI:0.62-0.81,P<.0001),但不预测复发(P=.4695)。
  • 简化量表在独立队列中验证,预测视觉恶化(OR/分:2.34,95%CI:1.33-4.14,P=.0032)和全切除(OR/分:0.73,95%CI:0.57-0.93,P=.0127),但不预测复发(P=.2572)。
  • 倾向匹配样本中,经颅入路与内镜下入路视觉恶化(P=.8757)和复发(P=.5678)无差异,但经颅入路全切除更可能(OR:1.49,95%CI:1.02-2.18,P=.0409)。
  • 匹配的术前有视觉缺损患者中,内镜下入路视觉改善更可能(72.9% vs 58.4%,P=.0010),视觉恶化率相等(内镜8.0% vs 经颅8.6%,P=.8018)。

关键数值与推荐

  • M-M量表评估肿瘤大小、视神经管侵犯和动脉受累。
  • 视觉恶化OR/分:1.22(95%CI:1.02-1.46,P=.0271);全切除OR/分:0.71(95%CI:0.62-0.81,P<.0001)。
  • 简化量表视觉恶化OR/分:2.34(95%CI:1.33-4.14,P=.0032);全切除OR/分:0.73(95%CI:0.57-0.93,P=.0127)。
  • 经颅入路全切除OR:1.49(95%CI:1.02-2.18,P=.0409)。
  • 内镜下入路视觉改善72.9% vs 经颅入路58.4%(P=.0010)。

临床怎么用

  • M-M量表可用于术前预测视觉恶化和切除程度。
  • 术前有视觉缺损者内镜下入路视觉改善更可能。
  • 作者认为,经验丰富的神经外科医生选择入路时需考虑个体肿瘤特征。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Tuberculum sellae meningiomas are resected via an expanded endonasal (EEA) or transcranial approach (TCA). Which approach provides superior outcomes is debated. The Magill-McDermott (M-M) grading scale evaluating tumor size, optic canal invasion, and arterial involvement remains to be validated for outcome prediction. The objective of this study was to validate the M-M scale for predicting visual outcome, extent of resection (EOR), and recurrence, and to use propensity matching by M-M scale to determine whether visual outcome, EOR, or recurrence differ between EEA and TCA. METHODS: Forty-site retrospective study of 947 patients undergoing tuberculum sellae meningiomas resection. Standard statistical methods and propensity matching were used. RESULTS: The M-M scale predicted visual worsening (odds ratio [OR]/point: 1.22, 95% CI: 1.02-1.46, P = .0271) and gross total resection (GTR) (OR/point: 0.71, 95% CI: 0.62-0.81, P < .0001), but not recurrence ( P = .4695). The scale was simplified and validated in an independent cohort for predicting visual worsening (OR/point: 2.34, 95% CI: 1.33-4.14, P = .0032) and GTR (OR/point: 0.73, 95% CI: 0.57-0.93, P = .0127), but not recurrence ( P = .2572). In propensity-matched samples, there was no difference in visual worsening ( P = .8757) or recurrence ( P = .5678) between TCA and EEA, but GTR was more likely with TCA (OR: 1.49, 95% CI: 1.02-2.18, P = .0409). Matched patients with preoperative visual deficits who had an EEA were more likely to have visual improvement than those undergoing TCA (72.9% vs 58.4%, P = .0010) with equal rates of visual worsening (EEA 8.0% vs TCA 8.6%, P = .8018). CONCLUSION: The refined M-M scale predicts visual worsening and EOR preoperatively. Preoperative visual deficits are more likely to improve after EEA; however, individual tumor features must be considered during nuanced approach selection by experienced neurosurgeons.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Magill ST, Schwartz TH, Couldwell WT, et al. International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach. Neurosurgery. 2023. PMID: 37418417. doi:10.1227/neu.0000000000002581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。